Cerebrolysin
Neuropeptide complex for brain health
Overview
Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue. It has neurotrophic properties similar to naturally occurring growth factors and is approved in many countries for neurological conditions.
Mechanism of Action
Contains multiple neurotrophic peptides → mimics BDNF, NGF, CNTF effects → promotes neuronal survival → enhances synaptic plasticity → reduces amyloid pathology → modulates GSK-3β and CDK5.
Benefits
- Neuroprotection
- Cognitive improvement
- Stroke recovery
- Alzheimer disease support
- TBI recovery
Dosing Protocol
Half-Life
~24 hours (composite effect)
Duration of pharmacological activity after administration.
Side Effects
- Dizziness
- Headache
- Injection site pain
- Agitation (rare)
- Hypersensitivity (rare)
Stacking Recommendations
Storage & Reconstitution
Store at room temperature (below 25°C). Protect from light. Amber ampules.
Research Notes
Approved in 40+ countries for stroke and dementia. Multiple large-scale clinical trials. Cochrane reviews show modest benefits in Alzheimer disease. Widely used in neurology across Europe and Asia.
Medical Disclaimer
This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Peptide therapy should only be initiated under the supervision of a qualified healthcare provider. Individual results may vary. Always consult with your physician before starting any new therapy. Regulatory status varies by jurisdiction.